Ironwood Pharmaceuticals (IRWD) Interest Coverage Ratio (2010 - 2026)
Ironwood Pharmaceuticals (IRWD) reported Interest Coverage Ratio of 7.94 for Q1 2026, up 320.11% on a YoY basis from 1.89 in Q1 2025, and up 538.53% sequentially from 1.24 in Q4 2025.
Ironwood Pharmaceuticals (IRWD) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Ironwood Pharmaceuticals (IRWD) has 17 years of Interest Coverage Ratio data on file, last reported at 7.94 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio rose 320.11% year-over-year to 7.94; the trailing twelve-month figure through Mar 2026 stood at 6.37 (down 32.09% YoY), and the FY2025 full-year result was 0.78, down 11.0% from the prior year.
- Interest Coverage Ratio rose to 7.94 in Q1 2026, from 1.24 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 44.93 in Q3 2022 to a low of 588.66 in Q2 2023.
- A 5-year average of 37.05 and a median of 3.69 in 2023 frame the typical range for Interest Coverage Ratio.
- Peak annual rise in Interest Coverage Ratio reached 440.57% in 2022, while the deepest fall reached 3037.24% in 2022.
- Tracing IRWD's Interest Coverage Ratio over 5 years: stood at 209.06 in 2022, then soared by 101.77% to 3.69 in 2023, then tumbled by 144.15% to 1.63 in 2024, then surged by 176.25% to 1.24 in 2025, then jumped by 538.53% to 7.94 in 2026.
- Business Quant data shows IRWD's Interest Coverage Ratio at 7.94 in Q1 2026, 1.24 in Q4 2025, and 8.95 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Ironwood Pharmaceuticals | 619.48 Mn | 399.01 Mn | - | 7.94 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.94 |
| Dec 31, 2025 | 1.24 |
| Sep 30, 2025 | 8.95 |
| Jun 30, 2025 | 5.42 |
| Mar 31, 2025 | -3.61 |
| Dec 31, 2024 | -1.63 |
| Sep 30, 2024 | 2.72 |
| Jun 30, 2024 | 3.34 |
| Mar 31, 2024 | 1.52 |
| Dec 31, 2023 | 3.69 |
| Sep 30, 2023 | 4.07 |
| Jun 30, 2023 | -588.66 |
| Mar 31, 2023 | 39.36 |
| Dec 31, 2022 | -209.06 |
| Sep 30, 2022 | 44.93 |
| Jun 30, 2022 | 25.22 |
| Mar 31, 2022 | 24.71 |
| Dec 31, 2021 | 7.12 |
| Sep 30, 2021 | 8.31 |
| Jun 30, 2021 | 8.42 |